Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients

Abstract Background Circumsporozoite protein (CSP) has a central immune domain that includes short regions of repeating amino acid sequences. This immunodynamic region is an epitope of B cells that can elicit an immune response in human and laboratory animals. The aim of the present study was to exp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mehdi Nateghpour, Soudabeh Etemadi, Afsaneh Motevalli Haghi, Hamid Eslami, Mehdi Mohebali, Leila Farivar
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
R
Acceso en línea:https://doaj.org/article/c4829955b1434b438ada41ee4c82c5ca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4829955b1434b438ada41ee4c82c5ca
record_format dspace
spelling oai:doaj.org-article:c4829955b1434b438ada41ee4c82c5ca2021-11-28T12:23:39ZSerological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients10.1186/s40001-021-00607-62047-783Xhttps://doaj.org/article/c4829955b1434b438ada41ee4c82c5ca2021-11-01T00:00:00Zhttps://doi.org/10.1186/s40001-021-00607-6https://doaj.org/toc/2047-783XAbstract Background Circumsporozoite protein (CSP) has a central immune domain that includes short regions of repeating amino acid sequences. This immunodynamic region is an epitope of B cells that can elicit an immune response in human and laboratory animals. The aim of the present study was to express the recombinant PvCSP-VK210 antigen and evaluate it for assaying antibodies obtained during human P. vivax infection by Western blotting and indirect ELISA (enzyme-linked immunosorbent assay). Method Genomic DNA of P. vivax was isolated from a blood sample of an Iranian person with vivax malaria, and by PCR, the fragment of the PvCSP-VK210 gene was amplified. The gene fragment was cut after gel purification by BamHI and HindIII enzymes and then cloned into pET28a expression vector. Finally, the recombinant pET28a was transformed into the E. coli BL21 (DE3) as the expression host. In order to produce His-tagged protein, the expression host was cultured in LB medium. The protein was purified by Ni–NTA columns and immobilized metal affinity chromatography, and after confirmation by Western blotting technique, was used as the antigen in the indirect ELISA test. Results The recombinant protein was expressed and purified as a 32-kDa protein. The sensitivity and specificity of the indirect ELISA test with the recombinant PvCSP-VK210 antigen were 61.42% and 97.14%, respectively, based on OD  =  0.313. Between the results of the microscopic test and the indirect ELISA test with the recombinant PvCSP-VK210 antigen there was a Kappa coefficient of 0.586. The positive and negative predictive value and validity of the ELISA test with the recombinant PvCSP-VK210 antigen were 95.55%, 71.57%, 79.28%, respectively. Conclusion The sensitivity of the indirect ELISA method with the recombinant PvCSP-VK210 antigen was 61.42%, which is the first report from Iran.Mehdi NateghpourSoudabeh EtemadiAfsaneh Motevalli HaghiHamid EslamiMehdi MohebaliLeila FarivarBMCarticlePlasmodium vivaxRecombinant circumsporozoite proteinVK210ELISAIranMedicineRENEuropean Journal of Medical Research, Vol 26, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Plasmodium vivax
Recombinant circumsporozoite protein
VK210
ELISA
Iran
Medicine
R
spellingShingle Plasmodium vivax
Recombinant circumsporozoite protein
VK210
ELISA
Iran
Medicine
R
Mehdi Nateghpour
Soudabeh Etemadi
Afsaneh Motevalli Haghi
Hamid Eslami
Mehdi Mohebali
Leila Farivar
Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
description Abstract Background Circumsporozoite protein (CSP) has a central immune domain that includes short regions of repeating amino acid sequences. This immunodynamic region is an epitope of B cells that can elicit an immune response in human and laboratory animals. The aim of the present study was to express the recombinant PvCSP-VK210 antigen and evaluate it for assaying antibodies obtained during human P. vivax infection by Western blotting and indirect ELISA (enzyme-linked immunosorbent assay). Method Genomic DNA of P. vivax was isolated from a blood sample of an Iranian person with vivax malaria, and by PCR, the fragment of the PvCSP-VK210 gene was amplified. The gene fragment was cut after gel purification by BamHI and HindIII enzymes and then cloned into pET28a expression vector. Finally, the recombinant pET28a was transformed into the E. coli BL21 (DE3) as the expression host. In order to produce His-tagged protein, the expression host was cultured in LB medium. The protein was purified by Ni–NTA columns and immobilized metal affinity chromatography, and after confirmation by Western blotting technique, was used as the antigen in the indirect ELISA test. Results The recombinant protein was expressed and purified as a 32-kDa protein. The sensitivity and specificity of the indirect ELISA test with the recombinant PvCSP-VK210 antigen were 61.42% and 97.14%, respectively, based on OD  =  0.313. Between the results of the microscopic test and the indirect ELISA test with the recombinant PvCSP-VK210 antigen there was a Kappa coefficient of 0.586. The positive and negative predictive value and validity of the ELISA test with the recombinant PvCSP-VK210 antigen were 95.55%, 71.57%, 79.28%, respectively. Conclusion The sensitivity of the indirect ELISA method with the recombinant PvCSP-VK210 antigen was 61.42%, which is the first report from Iran.
format article
author Mehdi Nateghpour
Soudabeh Etemadi
Afsaneh Motevalli Haghi
Hamid Eslami
Mehdi Mohebali
Leila Farivar
author_facet Mehdi Nateghpour
Soudabeh Etemadi
Afsaneh Motevalli Haghi
Hamid Eslami
Mehdi Mohebali
Leila Farivar
author_sort Mehdi Nateghpour
title Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
title_short Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
title_full Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
title_fullStr Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
title_full_unstemmed Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
title_sort serological responses to a soluble recombinant circumsporozoite protein-vk210 of plasmodium vivax (rpvcsp-vk210) among iranian malaria patients
publisher BMC
publishDate 2021
url https://doaj.org/article/c4829955b1434b438ada41ee4c82c5ca
work_keys_str_mv AT mehdinateghpour serologicalresponsestoasolublerecombinantcircumsporozoiteproteinvk210ofplasmodiumvivaxrpvcspvk210amongiranianmalariapatients
AT soudabehetemadi serologicalresponsestoasolublerecombinantcircumsporozoiteproteinvk210ofplasmodiumvivaxrpvcspvk210amongiranianmalariapatients
AT afsanehmotevallihaghi serologicalresponsestoasolublerecombinantcircumsporozoiteproteinvk210ofplasmodiumvivaxrpvcspvk210amongiranianmalariapatients
AT hamideslami serologicalresponsestoasolublerecombinantcircumsporozoiteproteinvk210ofplasmodiumvivaxrpvcspvk210amongiranianmalariapatients
AT mehdimohebali serologicalresponsestoasolublerecombinantcircumsporozoiteproteinvk210ofplasmodiumvivaxrpvcspvk210amongiranianmalariapatients
AT leilafarivar serologicalresponsestoasolublerecombinantcircumsporozoiteproteinvk210ofplasmodiumvivaxrpvcspvk210amongiranianmalariapatients
_version_ 1718408040537915392